Accretive Health, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2015. For the quarter, the company's net services revenue was $68,341,000 compared to $47,456,000 a year ago. Income from operations was $10,918,000 compared to loss of $31,570,000 a year ago. Income before income tax provision was $11,002,000 compared to loss of $31,520,000 a year ago. Net income was $5,447,000 or $0.06 per basic and diluted share, compared to loss of $17,651,000 or $0.18 per basic and diluted share a year ago. Adjusted EBITDA was $22,670,000 against loss of $6,462,000 a year ago. Net cash generated from customer contracting activities of $27.0 million, compared to $6.8 million for the fourth quarter of 2014. The strategic review process impacted ability to realize some projected opportunities at the end of the year, and results were consequently below expectations. However, despite this, the company delivered significant sequential improvement in the fourth quarter and over the prior year.

For the year, the company's net services revenue was $117,239,000 compared to $210,140,000 a year ago. Loss from operations was $136,044,000 compared to $128,653,000 a year ago. Loss before income tax provision was $135,813,000 compared to $128,351,000 a year ago. Net loss was $84,256,000 or $0.87 per basic and diluted share, compared to $79,620,000 or $0.83 per basic and diluted share, a year ago. Net cash used in operating activities was $23,812,000 compared to $77,236,000 a year ago. Purchases of property, equipment and software were $21,275,000 compared to $6,034,000 a year ago. Adjusted LBITDA was $86,568,000 against $15,668,000 a year ago.